These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 35733918)

  • 1. HIF-1
    Lyu Y; Zhang Y; Wang Y; Luo Y; Ding H; Li P; Ni G
    J Immunol Res; 2022; 2022():6130806. PubMed ID: 35733918
    [TBL] [Abstract][Full Text] [Related]  

  • 2. WTAP facilitates progression of hepatocellular carcinoma via m6A-HuR-dependent epigenetic silencing of ETS1.
    Chen Y; Peng C; Chen J; Chen D; Yang B; He B; Hu W; Zhang Y; Liu H; Dai L; Xie H; Zhou L; Wu J; Zheng S
    Mol Cancer; 2019 Aug; 18(1):127. PubMed ID: 31438961
    [TBL] [Abstract][Full Text] [Related]  

  • 3. m6A methyltransferase Wilms' tumor 1-associated protein facilitates cell proliferation and cisplatin resistance in NK/T cell lymphoma by regulating dual-specificity phosphatases 6 expression via m6A RNA methylation.
    Ma H; Shen L; Yang H; Gong H; Du X; Li J
    IUBMB Life; 2021 Jan; 73(1):108-117. PubMed ID: 33205540
    [TBL] [Abstract][Full Text] [Related]  

  • 4. METTL3 regulates m6A in endometrioid epithelial ovarian cancer independently of METTl14 and WTAP.
    Ma Z; Li Q; Liu P; Dong W; Zuo Y
    Cell Biol Int; 2020 Dec; 44(12):2524-2531. PubMed ID: 32869897
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Gene Signatures and Prognostic Values of m6A RNA Methylation Regulators in Ovarian Cancer.
    Han X; Liu J; Cheng G; Cui S
    Cancer Control; 2020; 27(1):1073274820960460. PubMed ID: 32951457
    [TBL] [Abstract][Full Text] [Related]  

  • 6. N6-Methyladenosine-Related RNA Signature Predicting the Prognosis of Ovarian Cancer.
    Jiao J; Jiang L; Luo Y
    Recent Pat Anticancer Drug Discov; 2021; 16(3):407-416. PubMed ID: 34137363
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tumor-associated macrophages promote cisplatin resistance in ovarian cancer cells by enhancing WTAP-mediated N6-methyladenosine RNA methylation via the CXCL16/CXCR6 axis.
    Hong L; Wang X; Zheng L; Wang S; Zhu G
    Cancer Chemother Pharmacol; 2023 Jul; 92(1):71-81. PubMed ID: 37272931
    [TBL] [Abstract][Full Text] [Related]  

  • 8. N
    Yu H; Zhao K; Zeng H; Li Z; Chen K; Zhang Z; Li E; Wu Z
    Biomed Pharmacother; 2021 Jan; 133():111075. PubMed ID: 33378974
    [TBL] [Abstract][Full Text] [Related]  

  • 9. WTAP Mediated the N6-methyladenosine Modification of PDK4 to Regulate the Malignant Behaviors of Colorectal Cancer Cells
    Dai X; Chen K; Xie Y
    Curr Med Chem; 2023; 30(29):3368-3381. PubMed ID: 36154586
    [TBL] [Abstract][Full Text] [Related]  

  • 10. WTAP-Mediated m6A RNA Methylation Regulates the Differentiation of Bone Marrow Mesenchymal Stem Cells via the miR-29b-3p/HDAC4 Axis.
    Liu J; You Y; Sun Z; Zhang L; Li X; Dai Z; Ma J; Chen Y; Jiao G
    Stem Cells Transl Med; 2023 May; 12(5):307-321. PubMed ID: 37010483
    [TBL] [Abstract][Full Text] [Related]  

  • 11. m
    Li G; Deng L; Huang N; Cui Z; Wu Q; Ma J; Pan Q; Sun F
    Genes (Basel); 2021 Oct; 12(11):. PubMed ID: 34828353
    [TBL] [Abstract][Full Text] [Related]  

  • 12. HBXIP drives metabolic reprogramming in hepatocellular carcinoma cells via METTL3-mediated m6A modification of HIF-1α.
    Yang N; Wang T; Li Q; Han F; Wang Z; Zhu R; Zhou J
    J Cell Physiol; 2021 May; 236(5):3863-3880. PubMed ID: 33305825
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Gemcitabine Inhibits the Progression of Pancreatic Cancer by Restraining the WTAP/MYC Chain in an m6A-Dependent Manner.
    Cao P; Zhang W; Qiu J; Tang Z; Xue X; Feng T
    Cancer Res Treat; 2024 Jan; 56(1):259-271. PubMed ID: 37591781
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Elevated WTAP promotes hyperinflammation by increasing m6A modification in inflammatory disease models.
    Ge Y; Chen R; Ling T; Liu B; Huang J; Cheng Y; Lin Y; Chen H; Xie X; Xia G; Luo G; Yuan S; Xu A
    J Clin Invest; 2024 May; 134(14):. PubMed ID: 39007267
    [TBL] [Abstract][Full Text] [Related]  

  • 15. High expression of WTAP leads to poor prognosis of gastric cancer by influencing tumour-associated T lymphocyte infiltration.
    Li H; Su Q; Li B; Lan L; Wang C; Li W; Wang G; Chen W; He Y; Zhang C
    J Cell Mol Med; 2020 Apr; 24(8):4452-4465. PubMed ID: 32176425
    [TBL] [Abstract][Full Text] [Related]  

  • 16. microRNA-671-5p reduces tumorigenicity of ovarian cancer via suppressing HDAC5 and HIF-1α expression.
    Peng D; Wu T; Wang J; Huang J; Zheng L; Wang P; Li J; Wu L; Luo M
    Chem Biol Interact; 2022 Mar; 355():109780. PubMed ID: 34990588
    [TBL] [Abstract][Full Text] [Related]  

  • 17. High Wilms' tumor 1 associating protein expression predicts poor prognosis in acute myeloid leukemia and regulates m
    Naren D; Yan T; Gong Y; Huang J; Zhang D; Sang L; Zheng X; Li Y
    J Cancer Res Clin Oncol; 2021 Jan; 147(1):33-47. PubMed ID: 32880751
    [TBL] [Abstract][Full Text] [Related]  

  • 18. N6-methyladenosine (m6A) RNA methylation mediated by methyltransferase complex subunit WTAP regulates amelogenesis.
    Xie F; Zhu X; Liu X; Chen H; Wang J
    J Biol Chem; 2022 Dec; 298(12):102715. PubMed ID: 36403857
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hypoxia induces chemoresistance of esophageal cancer cells to cisplatin through regulating the lncRNA-EMS/miR-758-3p/WTAP axis.
    Zhu ZJ; Pang Y; Jin G; Zhang HY; Wang WH; Liu JW; Tuo GX; Wu P; Yang Y; Wang ZQ; Wang K
    Aging (Albany NY); 2021 Jun; 13(13):17155-17176. PubMed ID: 34081626
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification of WTAP-related genes by weighted gene co-expression network analysis in ovarian cancer.
    Wang J; Xu J; Li K; Huang Y; Dai Y; Xu C; Kang Y
    J Ovarian Res; 2020 Sep; 13(1):119. PubMed ID: 32998774
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.